Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Bullboard Posts
Post by SLEDRECKSon Dec 07, 2018 5:50pm
235 Views
Post# 29085251

Today's hearing

Today's hearing I took this from the CEO.CA #allsharesmatter page. I recommend scrolling through. Some good info there. @tommy Friend who attended BCSC Bridgemark hearing today shared a few comments by phone. What follows is second-hand and may not be accurate. If you are new to this story, here's some background: https://biv.com/article/2018/12/massive-corrupt-bc-cannabis-crypto-mining-and-energy-shares-scheme-alleged The investigation is wide-reaching and in its early stages. The BCSC were apparently able to stop one of these transactions in progress. Apparently some bank accounts have also been frozen. The purpose of todays hearing was to extend temporary orders blocking CSE-listed companies from using the consultant exemption to sell shares to 25 persons and 26 firms listed in the investigation for the public interest. They requested until Feb 19 to conduct the investigation. The hearing was packed with 50+ people and a spillover room had another ~15. Mostly lawyers for the accused. My friend did not think the accused themselves were present at the hearing. Lawyers for the accused hinted at a possible defence strategy citing variations between the transactions and calling the BCSCs characterization of the group as the Bridgemark group prejudicial. They apparently do not refer to themselves this way. BCSC said the group followed the same pattern of purchases and sales, consulting agreements, funds received, etc. Rinse repeat. Two members of the Bridgemark group supposedly handled the consulting agreements for everyone. Apparently they were copying and pasting a consulting agreement and left the same document number on every agreement! Expect further hearings, announcements, and press coverage soon.
Bullboard Posts